HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The clinico-pathogenetic significance of general and local defense and injury factors in endometritis after cesarean section].

Abstract
Analysis of phagocytosis parameters in uterine lochia and measurements of polyvalent proteinase inhibitor and alkaline phosphatase activities, as well as of lipid peroxidation parameters in uterine lochia are recommended for the early diagnosis of endometritis following a cesarean section. Local changes in the defense and injurious factors forerun the development of an inflammation in the uterine cavity whereas systemic changes develop after the manifestation of clinical symptoms of endometritis. The findings indicate that development of endometritis following an abdominal delivery may be prevented by routine therapy supplemented by thymalin and intrauterine metronidazole. Therapy of endometritis developing after cesarean section should include immunomodulators, chosen individually, and administered in combination with intrauterine contrycal.
AuthorsIu P Vdovichenko
JournalAkusherstvo i ginekologiia (Akush Ginekol (Mosk)) Issue 11 Pg. 24-8 (Nov 1991) ISSN: 0300-9092 [Print] Russia (Federation)
Vernacular TitleKliniko-patogeneticheskoe znachenie obshchikh i mestnykh faktorov zashchity i povrezhdeniia pri éndometrite posle operatsii kesareva secheniia.
PMID1814221 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Adjuvants, Immunologic
Topics
  • Adjuvants, Immunologic (therapeutic use)
  • Adult
  • Cesarean Section
  • Diagnosis, Differential
  • Endometritis (drug therapy, etiology, immunology)
  • Female
  • Humans
  • Immunity, Innate (drug effects)
  • Postoperative Complications (drug therapy, etiology, immunology)
  • Pregnancy
  • Puerperal Disorders (drug therapy, etiology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: